Rare tumors, major challenges: The RACOON-SAGA project explores how imaging and clinical data can improve the pre-therapeutic characterization of soft tissue sarcomas. In this interview, Dr. Madelaine Hettler from University Medical Center Mannheim explains how radiology and surgery collaborate within the Network University Medicine — and why structured data are key to making therapy decisions more precise and personalized.
Rare Tumors, Big Goals: How RACOON-SAGA Aims to Improve Therapy Decisions
Related Resources
Postoperative Brain MRI After Tumor Resection: Reducing Artifacts and Improving Diagnostic Accuracy
Postoperative MRI after brain tumor surgery is often affected by artifacts caused by intracranial air, limiting reliable image interpretation.
A…
Read more
Integrated Data Management for Multicentric Imaging in Investigator-Initiated Trials (IITs)
Establishing a Framework for Multicentric Data Coordination
For many investigators, the transition from a single-site study to a multicentric model…
Read more
Bridging the Gap Between RECIST and Survival: Why the FDA’s Analysis of the g Value is a Game-Changer
For decades, oncology trials have relied on RECIST 1.1 to evaluate drug efficacy. However, these categorical "snapshot" evaluations do not always…
Read more